Patrys Limited has released a press release.
First Participants Dosed in RLS-2202 Phase 1A Clinical Trial
Earlier from Patrys
- PAB Establishes Clinical Advisory Committee
- Ethics Approval Secured for Phase 1A Clinical Trial
- Investor Presentation - TechKnow Invest Roadshow
- Appendix 4C - Quarterly - 30 June 2026